JW (KY) THERAPEUT. CO.LTDJW (KY) THERAPEUT. CO.LTDJW (KY) THERAPEUT. CO.LTD

JW (KY) THERAPEUT. CO.LTD

No trades
See on Supercharts
Market capitalization
‪84.74 M‬EUR
−0.239EUR
‪−98.44 M‬EUR
‪22.28 M‬EUR
‪380.85 M‬
Beta (1Y)
0.97

About JW (KY) THERAPEUT. CO.LTD

CEO
Yi Ping Li
Headquarters
Shanghai
Employees (FY)
398
Founded
2017
ISIN
KYG5210T1040
FIGI
BBG01JR76LQ1
JW (Cayman) Therapeutics Co. Ltd. is a clinical stage cell therapy company, which focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. The company was founded by Yi Ping Li on September 6, 2017 and is headquartered in Shanghai, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange JW (KY) THERAPEUT. CO.LTD stocks are traded under the ticker JNY.
JW (KY) THERAPEUT. CO.LTD is going to release the next earnings report on Aug 27, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for JW (KY) THERAPEUT. CO.LTD has a max estimate of 0.421 EUR and a min estimate of 0.260 EUR.
JNY earnings for the last quarter are −0.12 EUR per share, whereas the estimation was −0.11 EUR resulting in a −9.41% surprise. The estimated earnings for the next quarter are −0.10 EUR per share. See more details about JW (KY) THERAPEUT. CO.LTD earnings.
JW (KY) THERAPEUT. CO.LTD revenue for the last quarter amounts to ‪11.09 M‬ EUR despite the estimated figure of ‪20.74 M‬ EUR. In the next quarter revenue is expected to reach ‪12.32 M‬ EUR.
Yes, you can track JW (KY) THERAPEUT. CO.LTD financials in yearly and quarterly reports right on TradingView.
JNY net income for the last quarter is ‪−48.57 M‬ EUR, while the quarter before that showed ‪−50.32 M‬ EUR of net income which accounts for 3.48% change. Track more JW (KY) THERAPEUT. CO.LTD financial stats to get the full picture.
No, JNY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, JNY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JW (KY) THERAPEUT. CO.LTD stock right from TradingView charts — choose your broker and connect to your account.
JNY reached its all-time high on Nov 9, 2023 with the price of 0.330 EUR, and its all-time low was 0.180 EUR and was reached on Feb 2, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 398.00 employees. See our rating of the largest employees — is JW (KY) THERAPEUT. CO.LTD on this list?
We've gathered analysts' opinions on JW (KY) THERAPEUT. CO.LTD future price: according to them, JNY price has a max estimate of 0.42 EUR and a min estimate of 0.26 EUR. Read a more detailed JW (KY) THERAPEUT. CO.LTD forecast: see what analysts think of JW (KY) THERAPEUT. CO.LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JW (KY) THERAPEUT. CO.LTD EBITDA is ‪−61.82 M‬ EUR, and current EBITDA margin is −276.69%. See more stats in JW (KY) THERAPEUT. CO.LTD financial statements.